2023 Q1 Form 10-K Financial Statement

#000147793223000200 Filed on January 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q3 2022
Revenue $8.118K $3.280K $6.089K
YoY Change 767.31% -86.4% -93.57%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit $3.280K $6.089K
YoY Change -56.32% -88.46%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $648.4K $1.227M $5.011M
YoY Change -57.14% 29.77% 90.86%
% of Gross Profit 37414.02% 82290.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.74K $11.91K $47.62K
YoY Change -1.44% 0.0% 16.5%
% of Gross Profit 363.11% 781.98%
Operating Expenses $660.1K $1.239M $5.058M
YoY Change -56.71% 31.03% 92.67%
Operating Profit -$652.0K -$1.236M $1.639M
YoY Change -57.22% 31.73% -163.71%
Interest Expense -$11.31K $220.00 $48.83K
YoY Change 443.75% -101.04% -332.64%
% of Operating Profit 2.98%
Other Income/Expense, Net $11.31K $47.94K
YoY Change -9.54% 128.39%
Pretax Income -$663.3K -$1.236M -$5.100M
YoY Change -56.53% 28.8% 96.65%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$663.3K -$1.236M -$5.100M
YoY Change -56.53% 28.8% 96.65%
Net Earnings / Revenue -8170.87% -37670.12% -83759.27%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$3.257K -$14.23K
COMMON SHARES
Basic Shares Outstanding 383.7M shares 378.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $214.2K $755.1K $755.1K
YoY Change -89.99% 335.98% 335.98%
Cash & Equivalents $214.2K $755.1K $755.1K
Short-Term Investments
Other Short-Term Assets $118.6K $32.90K $32.90K
YoY Change -71.19% -96.0% -96.0%
Inventory $0.00 $0.00 $0.00
Prepaid Expenses $118.6K $32.90K
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $332.8K $788.0K $788.0K
YoY Change -86.96% -28.52% -28.52%
LONG-TERM ASSETS
Property, Plant & Equipment $99.35K $123.0K $123.0K
YoY Change -32.32% -27.91% -27.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $99.35K $123.0K $123.0K
YoY Change -32.32% -27.91% -27.91%
TOTAL ASSETS
Total Short-Term Assets $332.8K $788.0K $788.0K
Total Long-Term Assets $99.35K $123.0K $123.0K
Total Assets $432.2K $911.0K $911.0K
YoY Change -83.99% -28.44% -28.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $543.5K $180.4K $180.4K
YoY Change 299.85% 291.74% 1337.53%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $40.00K $0.00 $0.00
YoY Change
Long-Term Debt Due $60.00K
YoY Change
Total Short-Term Liabilities $695.6K $449.2K $449.2K
YoY Change 150.01% 10.43% 10.43%
LONG-TERM LIABILITIES
Long-Term Debt $19.71K $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $19.71K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $695.6K $449.2K $449.2K
Total Long-Term Liabilities $19.71K $0.00 $0.00
Total Liabilities $715.3K $449.2K $449.2K
YoY Change 157.09% 10.42% 10.43%
SHAREHOLDERS EQUITY
Retained Earnings -$29.64M -$27.88M
YoY Change 16.39% 22.39%
Common Stock $392.8K $379.8K
YoY Change 4.25% 28.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$283.1K $461.8K $461.8K
YoY Change
Total Liabilities & Shareholders Equity $432.2K $911.0K $911.0K
YoY Change -83.99% -28.44% -28.44%

Cashflow Statement

Concept 2023 Q1 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$663.3K -$1.236M -$5.100M
YoY Change -56.53% 28.8% 96.65%
Depreciation, Depletion And Amortization $11.74K $11.91K $47.62K
YoY Change -1.44% 0.0% 16.5%
Cash From Operating Activities -$229.2K -$814.2K -$2.382M
YoY Change -51.64% 141.23% 81.31%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K 0.000 $2.964M
YoY Change 318.87%
NET CHANGE
Cash From Operating Activities -229.2K -814.2K -$2.382M
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 300.0K 0.000 $2.964M
Net Change In Cash 70.84K -814.2K $581.9K
YoY Change -114.95% 136.67% -186.28%
FREE CASH FLOW
Cash From Operating Activities -$229.2K -$814.2K -$2.382M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$814.2K -$2.382M
YoY Change 145.96% 91.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
12551 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27694 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
0 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
78765 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
32897 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
772394 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
788019 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1102449 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122990 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
170605 usd
CY2022Q3 us-gaap Assets
Assets
911009 usd
CY2021Q3 us-gaap Assets
Assets
1273054 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
180633 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
46055 usd
CY2022Q3 us-gaap Liabilities
Liabilities
449217 usd
CY2021Q3 us-gaap Liabilities
Liabilities
406810 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
866244 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
911009 usd
CY2022 us-gaap Gross Profit
GrossProfit
6089 usd
CY2021 us-gaap Gross Profit
GrossProfit
52754 usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001383088
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
379760670 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
379760670 shares
CY2022 dei Entity Registrant Name
EntityRegistrantName
CYTTA CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
296236627 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q3 cyca Common Stock Par Or Stated Value Per Share1
CommonStockParOrStatedValuePerShare1
0.001
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-257458
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0505761
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5450 W Sahara Ave Suite 300A
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89146
CY2022 dei City Area Code
CityAreaCode
702
CY2022 dei Local Phone Number
LocalPhoneNumber
900-7022
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
59171632 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
383685670 shares
CY2022 dei Auditor Firm
AuditorFirmId
273
CY2022 dei Auditor Name
AuditorName
Prager Metis CPAs, LLC
CY2022 dei Auditor Location
AuditorLocation
Hackensack, New Jersey
CY2022Q3 us-gaap Deposits Assets
DepositsAssets
0 usd
CY2021Q3 us-gaap Deposits Assets
DepositsAssets
50400 usd
CY2022Q3 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
180407 usd
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
33427 usd
CY2021Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
21033 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3588 usd
CY2022Q3 cyca Stock To Be Issued
StockToBeIssued
54750 usd
CY2021Q3 cyca Stock To Be Issued
StockToBeIssued
323583 usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
296236627 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
379761 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
296237 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27956388 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23330612 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27875007 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22774905 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
461792 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1273054 usd
CY2022 us-gaap Revenues
Revenues
6089 usd
CY2021 us-gaap Revenues
Revenues
94626 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
41872 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
3915778 usd
CY2021 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1976471 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
5058255 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
2625302 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-5052166 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-2572548 usd
CY2022 us-gaap Interest Expense
InterestExpense
48831 usd
CY2021 us-gaap Interest Expense
InterestExpense
21784 usd
CY2022 cyca Interests And Other Incomes
InterestsAndOtherIncomes
-895 usd
CY2021 cyca Interests And Other Incomes
InterestsAndOtherIncomes
-795 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
47936 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20989 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5100102 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2593537 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5100102 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2593537 usd
CY2022 cyca Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2021 cyca Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.01
CY2022 cyca Outstanding Basic And Diluted Weighted Average Number Of Share
OutstandingBasicAndDilutedWeightedAverageNumberOfShare
358355926 shares
CY2021 cyca Outstanding Basic And Diluted Weighted Average Number Of Share
OutstandingBasicAndDilutedWeightedAverageNumberOfShare
294491512 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
866244 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1407150 usd
CY2022 cyca Series F Preferred Stock Issued For Cash Amount
SeriesFPreferredStockIssuedForCashAmount
2963500 usd
CY2022 cyca Common Stock Issued For Accounts Payable Amount
CommonStockIssuedForAccountsPayableAmount
325000 usd
CY2022 cyca Common Stock Issued For Conversion Of Series E Preferred Stock Amount
CommonStockIssuedForConversionOfSeriesEPreferredStockAmount
0 usd
CY2022 cyca Common Stock Issued For Conversion Of Series F Preferred Stock Amount
CommonStockIssuedForConversionOfSeriesFPreferredStockAmount
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5100102 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
461792 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
999906 usd
CY2021 cyca Common Stock Issued For Cash Amount
CommonStockIssuedForCashAmount
25000 usd
CY2021 cyca Common Stock Issued For Stock Payable Amount
CommonStockIssuedForStockPayableAmount
432000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1300375 usd
CY2021 cyca Common Stock Issued For Accounts Payable Amount
CommonStockIssuedForAccountsPayableAmount
20000 usd
CY2022 cyca Common Stock Issued For Conversion Of Series E Preferred Stock Amount
CommonStockIssuedForConversionOfSeriesEPreferredStockAmount
0 usd
CY2021 cyca Series E Preferred Stock Sold For Cash Amount
SeriesEPreferredStockSoldForCashAmount
682500 usd
CY2022 cyca Common Stock Issued For Conversion Of Series F Preferred Stock Amount
CommonStockIssuedForConversionOfSeriesFPreferredStockAmount
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2593537 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
866244 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-5100102 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2593537 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2178973 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1365667 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
47615 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
40866 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-78765 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44566 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27694 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27694 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1159 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
9410 usd
CY2022 cyca Increase Decrease In Vendor Deposits
IncreaseDecreaseInVendorDeposits
50400 usd
CY2021 cyca Increase Decrease In Vendor Deposits
IncreaseDecreaseInVendorDeposits
-50400 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
159578 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18846 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
167856 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
12551 usd
CY2022 cyca Increase Decrease In Dividend Payable
IncreaseDecreaseInDividendPayable
12394 usd
CY2021 cyca Increase Decrease In Dividend Payable
IncreaseDecreaseInDividendPayable
21033 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3588 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3588 usd
CY2022 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
0 usd
CY2021 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-50480 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2381574 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1313536 usd
CY2022 us-gaap Payments To Acquire Oil And Gas Equipment
PaymentsToAcquireOilAndGasEquipment
0 usd
CY2021 us-gaap Payments To Acquire Oil And Gas Equipment
PaymentsToAcquireOilAndGasEquipment
68414 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68414 usd
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2963500 usd
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
707500 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2963500 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
707500 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
581926 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-674450 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173196 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
847646 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
755122 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173196 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2021 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1407150 usd
CY2022 cyca Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
300000 usd
CY2021 cyca Common Stock Issued For Accounts Payable
CommonStockIssuedForAccountsPayable
20000 usd
CY2022 cyca Common Stock Issued During Period Shares Account Payable
CommonStockIssuedDuringPeriodSharesAccountPayable
1064757 shares
CY2022Q3 cyca Other Prepaid Expense Activity
OtherPrepaidExpenseActivity
1154 usd
CY2021Q3 cyca Other Prepaid Expense Activity
OtherPrepaidExpenseActivity
9410 usd
CY2022Q3 us-gaap General And Administrative Costs In Inventory Amount Incurred
GeneralAndAdministrativeCostsInInventoryAmountIncurred
78765 usd
CY2022Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
325000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021 us-gaap Depreciation
Depreciation
40866 usd
CY2021 cyca Share Base Compensation
ShareBaseCompensation
648831 usd
CY2021 us-gaap Officers Compensation
OfficersCompensation
156252 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 cyca Common Stock Par Or Stated Value Per Share1
CommonStockParOrStatedValuePerShare1
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
1638878 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
1025441 usd
CY2022 cyca Less Valuation Allowance
LessValuationAllowance
-1638878 usd
CY2021 cyca Less Valuation Allowance
LessValuationAllowance
-1025441 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd

Files In Submission

Name View Source Status
cyca-20220930_cal.xml Edgar Link unprocessable
0001477932-23-000200-index-headers.html Edgar Link pending
0001477932-23-000200-index.html Edgar Link pending
0001477932-23-000200.txt Edgar Link pending
0001477932-23-000200-xbrl.zip Edgar Link pending
cyca-20220930.xsd Edgar Link pending
cyca_10k.htm Edgar Link pending
cyca_ex311.htm Edgar Link pending
cyca_ex312.htm Edgar Link pending
cyca_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cyca-20220930_pre.xml Edgar Link unprocessable
cyca-20220930_lab.xml Edgar Link unprocessable
cyca-20220930_def.xml Edgar Link unprocessable
cyca_10k_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending